Search hospitals > Georgia > Augusta
MBCCOP - Medical College of Georgia Cancer Center
Claim this profileAugusta, Georgia 30912
Global Leader in Leukemia
Global Leader in Lymphoma
Conducts research for Breast Cancer
Conducts research for Solid Tumors
Conducts research for Acute Myeloid Leukemia
103 reported clinical trials
9 medical researchers
Summary
MBCCOP - Medical College of Georgia Cancer Center is a medical facility located in Augusta, Georgia. This center is recognized for care of Leukemia, Lymphoma, Breast Cancer, Solid Tumors, Acute Myeloid Leukemia and other specialties. MBCCOP - Medical College of Georgia Cancer Center is involved with conducting 103 clinical trials across 174 conditions. There are 9 research doctors associated with this hospital, such as Sharad Ghamande, Jorge Cortes, MD, Vamsi Kota, MD, and Girindra Raval, MD.Area of expertise
1Leukemia
Global LeaderTP53 positive
FLT3 positive
b2a2 (e13a2) positive
2Lymphoma
Global LeaderCD20 positive
t(11;14)
Stage I
Top PIs
Sharad GhamandeAugusta University Medical Center1 year of reported clinical research
Expert in Cancer
Expert in Breast Cancer
68 reported clinical trials
145 drugs studied
Jorge Cortes, MDGeorgia Cancer Center at Augusta University5 years of reported clinical research
Expert in Leukemia
Studies Myeloid Leukemia
14 reported clinical trials
19 drugs studied
Vamsi Kota, MDAugusta University Medical Center3 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
8 reported clinical trials
37 drugs studied
Girindra Raval, MDAugusta University Medical Center4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
7 reported clinical trials
11 drugs studied
Clinical Trials running at MBCCOP - Medical College of Georgia Cancer Center
Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Endometrial Cancer
Leukemia
Non-Small Cell Lung Cancer
Follicular Lymphoma
Multiple Myeloma
Cancer
Cervical Cancer
Epcoritamab + R2
for Follicular Lymphoma
This trial is testing a new drug combination to treat adults with a type of cancer called follicular lymphoma that has returned or resisted other treatments. The new drug, epcoritamab, is used with lenalidomide and rituximab to help the immune system fight the cancer. The study will check how safe and effective this treatment is.
Recruiting3 awards Phase 3
Axicabtagene Ciloleucel
for Lymphoma
The goal of this clinical study is to compare the study drug, axicabtagene ciloleucel, versus standard of care (SOC) in first-line therapy in participants with high-risk large B-cell lymphoma.
Recruiting2 awards Phase 3
Epcoritamab + R-CHOP
for Diffuse Large B-Cell Lymphoma
This trial tests a new drug called epcoritamab combined with a mix of cancer-fighting drugs in adults with a rare type of aggressive cancer called DLBCL. Epcoritamab helps the immune system attack cancer cells, while the other drugs work together to kill them. This combination has been used as the standard treatment for patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) for many years.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at MBCCOP - Medical College of Georgia Cancer Center?
MBCCOP - Medical College of Georgia Cancer Center is a medical facility located in Augusta, Georgia. This center is recognized for care of Leukemia, Lymphoma, Breast Cancer, Solid Tumors, Acute Myeloid Leukemia and other specialties. MBCCOP - Medical College of Georgia Cancer Center is involved with conducting 103 clinical trials across 174 conditions. There are 9 research doctors associated with this hospital, such as Sharad Ghamande, Jorge Cortes, MD, Vamsi Kota, MD, and Girindra Raval, MD.